Recruiting

Stellate Ganglion Block

Sponsor:

University of Texas Southwestern Medical Center

Code:

NCT06797752

Conditions

OCTA

Severe Brain Injury

Subarachnoid Hemorrhage

Intracerebral Hemorrhage

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OCTA Scan

Study Details

Brief summary:

Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).

Conditions

OCTA

Severe Brain Injury

Subarachnoid Hemorrhage

Intracerebral Hemorrhage

Study ID

NCT06797752

Start date

Oct 7, 2024

Status verified date

Nov, 2025

Completion date

Oct 7, 2026

Anticipated

Primary completion date

Oct 7, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18 years or older
  • Patients receiving the stellate ganglion nerve block for an approved indication, e.g. complex regional pain syndrome

Exclusion Criteria:

  • Pregnancy
  • Non-English speaking
  • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Arms

Intervention Group

Patients receiving the stellate ganglion block

Interventions

OCTA Scan

Optical Coherence Tomography Angiography before and after receiving the stellate ganglion nerve block.

Primary outcome measure

  • Vascular and Perfusion Density [ Time Frame: One day ]

Central Contacts and Locations

Central contacts

Locations

UT Southwestern Medical Center

Recruiting

Dallas, Texas, United States, 75235

Contacts

Principal Investigator:

Noah Jouett, DO, PhD

More Information

Sponsor

University of Texas Southwestern Medical Center

Last update posted

Nov 19, 2025

Last verified

Nov, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Texas Southwestern Medical Center on 2025-11-19.